trending Market Intelligence /marketintelligence/en/news-insights/trending/3wep5ObfxLwwMgNabIVVJg2 content esgSubNav
In This List

Oncolix appoints board member

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Oncolix appoints board member

Oncolix Inc. appointed John Holaday as an independent board member.

Holaday's appointment makes him one of two independent directors, fulfilling an OTC-QB listing requirement.

Holaday is the co-founder, and most recently CEO, managing director and board member of QRxPharma Ltd.